Life Extension Ventures
www.lifex.vcVCMatch tracks Life Extension Ventures as an investor focused on Climate/Cleantech, Digital Health, and Biotech companies and United States, Europe, and Global markets. Upload your deck to compare your startup against the full private matching profile.
Check Size
Not specified
Stages
Not specified
Focus Areas
Geography
United States, Europe, and Global
Investment Thesis
LifeX invests at the intersection of scientific breakthroughs and software-powered commercialization. The firm focuses on accelerating both innovation and adoption of science-driven solutions for human and planetary health by backing the infrastructure and go-to-market primitives that enable those breakthroughs to scale. This is reflected in their emphasis on “Breakthroughs for carbon and climate,” “Revolutions in longevity and [health],” and the belief that “Software, AI, and the power of the Internet will accelerate the adoption and monetization of science breakthroughs on human and planetary life.”
Is Life Extension Ventures right for your startup?
Upload your pitch deck to compare your startup against VCMatch's private investor profile, including fit, timing, and next-step signals.
Investment Focus
Who should take a closer look
Life Extension Ventures is most relevant for founders raising venture-backed rounds in Climate/Cleantech, Digital Health, Biotech, and AI/ML, especially across United States, Europe, and Global.
Focus statement
They target science-driven opportunities (climate/carbon, longevity/health) and the software/infrastructure — SaaS, data platforms, GenAI, marketplaces, Web3/DAOs, APIs, payments and new go-to-market models — that accelerate commercialization and adoption. In their words: "We target the infrastructure that accelerates the innovations."
Value Add
- Founding team and partners are "scientists turned serial tech entrepreneurs" (Amol and Inaki), combining deep scientific literacy with multiple operator/CEO exits and fundraising experience.
- Hands-on operator network: mix of founders, CEOs, M&A dealmakers and global operators who say "Founders call us when they have a complex CEO decision."
- Dual emphasis on scientific impact and internet/software-driven commercialization — explicitly marrying "science breakthroughs" with "Software, AI, and the power of the Internet."
- Focus on novel commercialization primitives ("marketplaces, networks, Web3, personalizations, payments, APIs, new go-to-markets and operations") rather than only upstream science.
- Team background breadth across biotech/health, climate, product/technology and GTM (bioscience PhDs, MDs, Harvard/MIT/Stanford alumni, former Twitter/Spotify/Product leaders).
Stage And Sector Fit
Portfolio Highlights
Virgin Mobile USA
Telecom
Peek
Consumer
Halo Neuroscience
Healthtech
Knotable
Enterprise Saas
Knotel
Proptech
Idoven
Healthtech
Ontruck
Logistics
Alibaba
Ecommerce
+ 24 more companies in their portfolio
Ready to find your perfect investor match?
Get Started Free